shr0534
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT02749097)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Free fatty acid receptor 1AGONIST
FFAR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- shr0534
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03006159 | Phase 1 | Mar 1, 2015 | Hengrui Therapeutics, Inc. |
| NCT02750553 | Phase 1 | Jan 1, 2015 | Hengrui Therapeutics, Inc. |
| NCT02749097 | Phase 1 | Oct 1, 2013 | Hengrui Therapeutics, Inc., ICON |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 1 | 2013 |
| ICON | For profit | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1